Research Topics
| Per FranssonSummaryCountry: Sweden Publications
|
Detail Information
Publications
Quality of life for members of Swedish Prostate Cancer Patient AssociationsPer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Cancer Nurs 31:23-31. 2008..These findings show that it is possible to gain valid data to further study the situation of patients living with prostate cancer by collecting data from PCPAs...
Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic BeamCath techniquePer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Acta Oncol 42:326-33. 2003..Dose-escalation radiotherapy of prostate cancer using the BeamCath technique did not induce any significant increase in late side effects in comparison with conformal technique...- Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancerPer Fransson
Department of Radiation Sciences, Oncology, Umea University, Sweden
Acta Oncol 44:355-61. 2005..Age did not influence the recall bias. More precise data on impairments in QoL after EBRT in patients with LPC are therefore obtained from baseline and prospective follow-up studies... - Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath techniquePer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Int J Radiat Oncol Biol Phys 66:430-8. 2006..Late side effects were prospectively evaluated up to 5 years after dose-escalated external beam radiotherapy (EBRT) and were compared with a previously treated series with conventional conformal technique... - 15-year prospective follow-up of patient-reported outcomes of late bowel toxicity after external beam radiotherapy for localized prostate cancer. A comparison with age-matched controlsPer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Acta Oncol 46:517-24. 2007..The proportion of patients reporting late bowel symptoms was unchanged 15 years after EBRT in comparison to the 4-year follow-up. Increased bowel symptoms were seen in patients in comparison to the age-matched controls... - Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer--15 years' follow-up. A comparison with age-matched controlsPer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Acta Oncol 47:852-61. 2008..To prospectively examine the urinary toxicity and quality of life (QOL) in patients 15 years after external beam radiotherapy (EBRT) for localized prostate cancer (LPC) and compare the outcomes with results for age-matched controls... - Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controlsPer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Urol Oncol 29:137-44. 2011..The current study is a prolonged 15-year follow-up with the same cohorts... - Health-related quality of life 10 years after external beam radiotherapy or watchful waiting in patients with localized prostate cancerPer Fransson
Department of Oncology, Umea University, Umea, Sweden
Scand J Urol Nephrol 43:119-26. 2009..To evaluate long-term randomized comparisons of patient-reported outcome of symptoms and health-related quality of life (HRQoL) in men with localized prostate cancer 10 years after external beam radiotherapy (RT) or watchful waiting (WW)... - Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trialPer Fransson
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Lancet Oncol 10:370-80. 2009..We aimed to assess quality of life in men with locally advanced prostate cancer in an open-label phase III randomised comparison between lifelong endocrine treatment with and without radiotherapy... - Prospective evaluation of urinary and intestinal side effects after BeamCath stereotactic dose-escalated radiotherapy of prostate cancerPer Fransson
Department of Radiation Sciences, Oncology, , S-901 85 Ume, Sweden
Radiother Oncol 63:239-48. 2002..CONCLUSIONS: The stereotactic BeamCath EBRT technique facilitates safe dose escalation of patients with prostate cancer... - Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trialAnders Widmark
Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden
Lancet 373:301-8. 2009..To assess the effect of radiotherapy, we did an open phase III study comparing endocrine therapy with and without local radiotherapy, followed by castration on progression... - Fatigue in prostate cancer patients treated with external beam radiotherapy: a prospective 5-year long-term patient-reported evaluationPer Fransson
Department of Nursing, Umea University, SE 901 87 Umea, Sweden
J Cancer Res Ther 6:516-20. 2010..Limited information is available regarding the long-term effect of external beam radiotherapy (EBRT) on fatigue in individuals with prostate cancer (PC)... - Use of a modified ESAS in cancer patients: a pilot study of patient and staff experiencesKerstin Baba
Department of Oncology, Umea University Hospital, Sweden
Int J Palliat Nurs 13:610-6. 2007..To evaluate the feasibility of a modified Edmonton Symptom Assessment Scale (ESAS) for monitoring symptoms in oncological palliative care...